PTH and chronic kidney disease: Our analysis demonstrated that a notable proportion of patients with CKD stage 3–5ND exhibited high PTH levels: 59.3% when applying the KDOQI cut-off, and 40.2% when using the tertile-based PTH cut-off (PTH levels ≥166 ng/L).